Muller E, Rolla M, Ghigo E, Belliti D, Arvat E, Andreoni A
Drugs. 1995; 50(5):805-37.
PMID: 8586028
DOI: 10.2165/00003495-199550050-00004.
MEDRI G, Carella C, Padmanabhan V, Rossi C, Amato G, De Santo N
J Endocrinol Invest. 1993; 16(3):169-74.
PMID: 7685785
DOI: 10.1007/BF03344939.
Harrower A
Postgrad Med J. 1980; 56(657):481-4.
PMID: 6777767
PMC: 2425807.
DOI: 10.1136/pgmj.56.657.481.
Legros J, Ferreira de Almeida D, Servais J, Chiodera P, Thibaut A, Franchimont P
J Endocrinol Invest. 1983; 6(2):129-33.
PMID: 6408156
DOI: 10.1007/BF03350585.
Holl R, Loos U, Hetzel W, Heinze E, Fehm H
J Endocrinol Invest. 1988; 11(3):219-23.
PMID: 3286744
DOI: 10.1007/BF03350139.
Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man.
ZANOBONI A, Gibillini M, Cucchi M, Zanoboni Muciaccia W, ZANUSSI C
J Endocrinol Invest. 1988; 11(6):413-7.
PMID: 3145297
DOI: 10.1007/BF03349071.
Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor.
Cook D, GREER M, Paxton H
West J Med. 1987; 147(2):161-4.
PMID: 3116772
PMC: 1025768.
Effects of intravenous TRH on growth hormone and cortisol serum levels in children and adolescents with insulin dependent diabetes mellitus.
Vanelli M, Bernasconi S, BOLONDI O, Mami C, Pandullo E, Scaffidi M
J Endocrinol Invest. 1986; 9(4):293-7.
PMID: 3097114
DOI: 10.1007/BF03346930.
The paradoxical response of growth hormone (GH) to thyrotropin-releasing hormone (TRH) in constitutionally tall children involves a cholinergic pathway.
Arteaga E, Valenzuelaa P, Cattani A, Del Valle M
J Endocrinol Invest. 1989; 12(8):543-8.
PMID: 2512341
DOI: 10.1007/BF03350756.
Inappropriate growth-hormone (GH) response to thyrotropin-releasing hormone (TRH) occurs infrequently in well-regulated diabetes mellitus.
Giampietro O, Ferdeghini M, Miccoli R, Gregori G, Penno G, Bertoli S
Acta Diabetol Lat. 1990; 27(2):119-27.
PMID: 2116057
DOI: 10.1007/BF02581284.
Altered growth hormone response after growth hormone releasing hormone administration in chronic renal failure.
Garcia R, Andrade A, Perez J, Courel M, Casanueva F
J Endocrinol Invest. 1991; 14(5):383-9.
PMID: 1908493
DOI: 10.1007/BF03349087.
Long-term haemodialysis and thyroid function.
Dandona P, Newton D, Platts M
Br Med J. 1977; 1(6054):134-6.
PMID: 401663
PMC: 1603907.
DOI: 10.1136/bmj.1.6054.134.
Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.
Scanlon M, Pourmand M, McGregor A, Rodriguez-Arnao M, Hall K, Gomez-Pan A
J Endocrinol Invest. 1979; 2(3):307-31.
PMID: 231066
DOI: 10.1007/BF03350424.
[Stimulation of growth hormone and prolactin secretion with TRH in acromegaly (author's transl)].
von Werder K, Fahlbusch R, Gay R, Pickhardt C, Schultz B
Klin Wochenschr. 1976; 54(7):335-8.
PMID: 177804
DOI: 10.1007/BF01471580.
Suppression of clonidine-induced release of growth hormone by thyrotropin releasing hormone in humans.
ZANOBONI A, ZANUSSI C, Baraldi R
J Endocrinol Invest. 1979; 2(4):347-51.
PMID: 119798
DOI: 10.1007/BF03349332.
The effect of TRH on the release of TSH, PRL and GH in man under basal conditions and following methysergide.
Collu R
J Endocrinol Invest. 1978; 1(2):121-4.
PMID: 114568
DOI: 10.1007/BF03350358.
